Most Recent

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

0 Comments

image: Opinion: Pay-to-Play Publishing

Opinion: Pay-to-Play Publishing

By | September 3, 2015

Online scientific journals are sacrificing the quality of research articles to make a buck.

2 Comments

image: Opinion: Experiences of an Itinerant Scientist

Opinion: Experiences of an Itinerant Scientist

By | July 14, 2015

What I’ve learned doing science in three different countries 

1 Comment

image: Opinion: How Postdocs Can Participate

Opinion: How Postdocs Can Participate

By | September 18, 2014

Graduate students and postdoctoral researchers should be taking part in discussions on the future of biomedical research.

6 Comments

image: Opinion: A Role for Community Science Clubs

Opinion: A Role for Community Science Clubs

By , and | July 29, 2014

How retired scientists can enhance science education where they reside

2 Comments

image: Opinion: The Pitfalls of Uncertainty

Opinion: The Pitfalls of Uncertainty

By | April 14, 2014

How to successfully inform policy when scientific evidence is not plainly evident.

2 Comments

image: Opinion: Researching the Researchers

Opinion: Researching the Researchers

By | November 25, 2013

The biomedical research community is due for some self-reflection.

9 Comments

image: Opinion: Who We Work For

Opinion: Who We Work For

By | November 5, 2013

On winning hearts, minds, and votes for science

1 Comment

image: Opinion: The Payoff of Big Science

Opinion: The Payoff of Big Science

By | June 3, 2013

Was the Human Genome Project the key to a gold mine?

3 Comments

image: Opinion: Canadian Science Under Attack

Opinion: Canadian Science Under Attack

By | April 2, 2013

Government policies are shuttering research facilities while muzzling federal researchers by dissuading them from talking to the press, participating in international collaborations, or publishing their work.

6 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech